Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Transactions / W•••••• P••••• L••

W•••••• P••••• to Invest in Everise and Partner with B••••••••• for the Next Phase of Growth Oct 3, 2023

Platform acquisitionannouncedannounced Oct 3, 2023Fact
What happened
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
unknown
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
5 named
Buy side
  • A••••• J••••Deal partnerconfirmed
    A••••• J••••, Managing Partner at B•••••••••, said: “Since our investment in Everise in 2020, the company has delivered strong organic growth following investments in technology and operations and has become a strategic partner for its customers around the world.
  • B••••••••• Business Partners is the flagship listed vehicle of B••••••••• Asset Management’s Private Equity Group.
Side not stated
  • S•••••• A••••••, Managing Director of W•••••• P•••••, said, “We are pleased to partner with B••••••••• in our shared vision to elevate Everise into a next-generation global leader in the healthcare customer experience industry.
  • V•••• S••••••, Managing Director of W•••••• P•••••, added, “W•••••• P••••• has been an active investor in the global outsourced technology-enabled services space, and Everise presents an attractive platform to offer such services to the global healthcare payer and provider ecosystem.
  • W•••••• P••••• joins existing investor B••••••••• and both investors are committed to accelerating the growth trajectory of the company through business expansion and M&A. W•••••• P•••••’ investment values the company at around $1 billion.
Evidence
W•••••• P••••• joins existing investor B••••••••• and both investors are committed to accelerating the growth trajectory of the company through business expansion and M&A. W•••••• P•••••’ investment values the company at around $1 billion.
W•••••• P••••• to Invest in Everise and Partner with B••••••••• for the Next Phase of Grow | Private Equity Intelligence | DFX